C Fucini1, R Gattai, C Urena, L Bandettini, C Elbetti. 1. Department of Medical and Surgical Critical Care, Section of General and Oncological Surgery, University of Florence, Viale Morgagni, 85, 50134, Firenze, Italy. claudio.fucini@unifi.it
Abstract
BACKGROUND: Low rectal cancers situated less than 5 cm from the anal margin are still usually treated with abdomino-perineal excision (APE). Our aim is to compare the quality of life (QOL) of five-year survivors treated for low or very low rectal cancer with an advanced/complex coloanal procedure with the QOL of patients submitted to a standard APE with a definitive abdominal stoma. METHODS: Sixty-two patients, operated on radically for low or very low rectal cancer, who came for their fifth year follow-up visit and were free from cancer, were studied. Thirty patients (group 1) had an APE with permanent abdominal stoma. Thirty-two patients (group 2) had undergone a radical advanced and complex procedure to avoid the abdominal stoma. The patients received the European Organisation for the Research and Treatment of Cancer (EORTC) QOL-30 generic and the CR38 colorectal cancer QOL questionnaires with the recommendation to return the questionnaire to the hospital. The Mann-Whitney U-test and chi (2) Fisher test were employed for statistical analysis. RESULTS: All questionnaires were returned. Patients without a terminal abdominal stoma had a better score in six categories of the QOL 30 and in two categories of the CR38. No differences were observed in the other variables examined. CONCLUSIONS: After five years, cancer-free patients operated on for low or very low rectal cancer have a better QOL if a definitive terminal abdominal stoma was avoided.
BACKGROUND:Low rectal cancers situated less than 5 cm from the anal margin are still usually treated with abdomino-perineal excision (APE). Our aim is to compare the quality of life (QOL) of five-year survivors treated for low or very low rectal cancer with an advanced/complex coloanal procedure with the QOL of patients submitted to a standard APE with a definitive abdominal stoma. METHODS: Sixty-two patients, operated on radically for low or very low rectal cancer, who came for their fifth year follow-up visit and were free from cancer, were studied. Thirty patients (group 1) had an APE with permanent abdominal stoma. Thirty-two patients (group 2) had undergone a radical advanced and complex procedure to avoid the abdominal stoma. The patients received the European Organisation for the Research and Treatment of Cancer (EORTC) QOL-30 generic and the CR38 colorectal cancer QOL questionnaires with the recommendation to return the questionnaire to the hospital. The Mann-Whitney U-test and chi (2) Fisher test were employed for statistical analysis. RESULTS: All questionnaires were returned. Patients without a terminal abdominal stoma had a better score in six categories of the QOL 30 and in two categories of the CR38. No differences were observed in the other variables examined. CONCLUSIONS: After five years, cancer-freepatients operated on for low or very low rectal cancer have a better QOL if a definitive terminal abdominal stoma was avoided.
Authors: Roman A Inglin; Daniel Eberli; Lukas E Brügger; Tullio Sulser; Norman S Williams; Daniel Candinas Journal: Int J Colorectal Dis Date: 2014-11-19 Impact factor: 2.571
Authors: Drew J Gunnells; Lauren N Wood; Lauren Goss; Melanie S Morris; Gregory D Kennedy; Jamie A Cannon; Daniel I Chu Journal: J Gastrointest Surg Date: 2017-07-28 Impact factor: 3.452
Authors: A Mariani; D Moszkowicz; C Trésallet; F Koskas; L Chiche; R Lupinacci; F Menegaux Journal: Tech Coloproctol Date: 2014-01-17 Impact factor: 3.781
Authors: J B Reese; P H Finan; J A Haythornthwaite; M Kadan; K R Regan; J M Herman; J Efron; L A Diaz; N S Azad Journal: Support Care Cancer Date: 2013-10-05 Impact factor: 3.603
Authors: Sang Woo Lim; Hun Jin Kim; Chang Hyun Kim; Jung Wook Huh; Young Jin Kim; Hyeong Rok Kim Journal: Langenbecks Arch Surg Date: 2012-12-09 Impact factor: 3.445
Authors: Carol M Baldwin; Marcia Grant; Christopher Wendel; Mark C Hornbrook; Lisa J Herrinton; Carmit McMullen; Robert S Krouse Journal: J Clin Sleep Med Date: 2009-08-15 Impact factor: 4.062
Authors: Axel Kleespies; Kathrin E Füessl; Hendrik Seeliger; Martin E Eichhorn; Mario H Müller; Markus Rentsch; Wolfgang E Thasler; Martin K Angele; Martin E Kreis; Karl-Walter Jauch Journal: Int J Colorectal Dis Date: 2009-06-03 Impact factor: 2.571